ANIP FY 2014 Earnings — ANI Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ANIPANI Pharmaceuticals, Inc.

$2B

FY 2014 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$56M+86.1% YoY

Gross Profit

$44M79.5% margin

Operating Income

$20M35.7% margin

Net Income

$29M51.4% margin

EPS (Diluted)

$2.59

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

-$14M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$264M

Total Liabilities

$124M

Stockholders' Equity

$140M

Cash & Equivalents

$169M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$56M	$30M	+86.1%
Gross Profit	$44M	$20M	+121.3%
Operating Income	$20M	$898,000	+2127.8%
Net Income	$29M	$301,000	+9450.5%